NASDAQ: PBYI
Puma Biotechnology Inc Stock Ownership - Who owns Puma Biotechnology?

Insider buying vs selling

Have Puma Biotechnology Inc insiders been buying or selling?

Buy
Sell
NameRoleDateSharesPriceValue
Brian M. StuglikDirector2025-06-138,100$3.39
$27.46kSell
Adrian SenderowiczDirector2025-06-1327,000$3.40
$91.80kSell
Jay M. MoyesDirector2025-06-1322,000$3.40
$74.80kSell
Allison DorvalDirector2025-06-1311,610$3.40
$39.47kSell
Troy Edward WilsonDirector2025-06-1310,800$3.40
$36.72kSell
Alessandra CesanoDirector2025-06-1312,150$3.40
$41.31kSell
Jeffrey Jerome LudwigChief Commercial Officer2025-01-029,437$3.15
$29.75kSell
Alan H. AuerbachPresident and CEO2025-01-0233,841$3.15
$106.67kSell
Douglas M. HuntOfficer2025-01-028,633$3.15
$27.21kSell
Maximo F. NouguesChief Financial Officer2025-01-0210,227$3.15
$32.24kSell

1 of 2

PBYI insiders have sold more... subscribe to Premium to read more.
Net Insider Buy/Sell (L12M) Ownership

Be the first to know when PBYI insiders and whales buy or sell their stock.

PBYI Shareholders

What type of owners hold Puma Biotechnology Inc stock?

Institutional
Insider
Retail
NameHoldSharesValueType
Adage Capital Partners GP LLC17.89%8,879,139$31.79MInsider
Alan H. Auerbach14.56%7,228,073$25.88MInsider
Acorn Capital Advisors LLC7.94%3,940,052$14.11MInstitution
Blackrock Inc7.75%3,847,368$13.77MInstitution
Vanguard Group Inc7.39%3,669,263$13.14MInstitution
Adage Capital Partners LP6.45%3,200,000$11.46MInsider
Acadian Asset Management LLC4.05%2,008,146$7.19MInstitution
Renaissance Technologies LLC3.69%1,829,213$6.55MInstitution
Millennium Management LLC2.79%1,385,194$4.96MInstitution
American Century Companies Inc2.32%1,149,660$4.12MInstitution

1 of 3

PBYI vs Biotech Stocks

TickerInst. %Insider %Net Insider (L12M)Net Insider (L3M)
PBYI58.23%41.77%Net SellingNet Selling
NVCT8.66%44.05%Net BuyingNet Buying
VYGR54.09%45.91%Net Selling
IMAB4.79%0.00%
TIL6.45%93.55%

Puma Biotechnology Stock Ownership FAQ

Who owns Puma Biotechnology?

Puma Biotechnology (NASDAQ: PBYI) is owned by 61.27% institutional shareholders, 43.94% Puma Biotechnology insiders, and 0.00% retail investors. Adage Capital Partners GP LLC is the largest individual Puma Biotechnology shareholder, owning 8.88M shares representing 17.89% of the company. Adage Capital Partners GP LLC's Puma Biotechnology shares are currently valued at $31.79M.

If you're new to stock investing, here's how to buy Puma Biotechnology stock.
WallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.

Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.